Eli Lilly expects FDA to apply for Zepbound for sleep apnea in the short term
Eli Lilly On Friday it said it applied for U.S. approval of its weight-loss drug Zepbound for the treatment of…
health care industry
Paradromics prepares to test its brain implant in humans
Neurotech startup Paradromics will test its brain implant next year, as the race to be a leader in the nascent…
Catalyst Calendar: Here's a Look at the Major Events That Could Drive These 7 Stocks Higher
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
Gilead PrEP lenacapavir succeeds in phase 3 trial
The logo of the pharmaceutical company Gilead Sciences in Oceanside, California, on April 29, 2020. Mike Blake | Reuters GileadThe…
More US employers cover GLP-1 for weight loss
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Wegovy injectable…
FDA approves Merck vaccine against pneumococcal disease designed for adults
Zoom in iconArrows pointing outwards Merck's new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved merckThe…
Eli Lilly, CFO Anat Ashkenazi on managing growing demand for LPG-1
A pharmacist holds boxes of Eli Lilly & Co. Mounjaro brand tirzepatide arranged at a pharmacy in Provo, Utah, U.S.,…
The 4 things we're most focused on in the stock market this week
The Nasdaq Composite rose slightly on Friday for its fifth consecutive record close, as new data last week showed a…
Google-Backed Tempus AI Jumps Up to 15% in Nasdaq Debut
Tempus AI, a healthcare diagnostics company that uses artificial intelligence to interpret medical tests and help doctors provide more accurate…
Supreme Court rejects attempt to restrict access to the abortion pill
Mifepristone, also known as RU-486, is a medication typically used in combination with misoprostol to induce medical abortion during pregnancy…